August 31, 2011

TGaS Advisors Named to Inc. 5000; Among Top Health Companies, Top 50 in Philadelphia Metro Area

TGaS® Advisors, a leading benchmarking and advisory services firm for the pharmaceutical industry, has been recognized for the fourth year in a row as one of America's fastest growing companies in the United States by Inc. Magazine in its 2011 rankings.

TGaS Advisors ranks #1443 in the Inc 5000 and is listed as one of the Top Health Companies. It also ranks in the Top 50 in the Philadelphia Metro Area. Earlier this year the firm was named one of the leading entrepreneurial businesses in the Philadelphia region by Philadelphia SmartCEO magazine, receiving its prestigious Future 50 award. TGaS Advisors is now a division of KnowledgePoint360.

In the face of downward economic trends, TGaS Advisors revenue nearly tripled over the three years from 2007-2010. According to Stephen E. Gerard, TGaS Advisors Founder and President, "Pharmaceutical companies see efficiency and profitability as key drivers in this challenging environment. Commercial Operations executives increasingly understand that TGaS Advisors can help them become valued business partners in this effort." Gerard cited findings from the recent White Paper he co-authored with TGaS Advisors Vice President and Management Advisor Anna McClafferty, "The New Commercial Model: Reality or Rhetoric?"

TGaS Advisors recently launched several new Commercial Operations benchmark options in Managed Markets and in Marketing Operations, including Medical/Regulatory/Legal Review and Speaker Management, currently two "hot-button" issues for pharmaceutical companies. In addition, five senior executives joined the firm in 2011, including new leadership for Training & Development, the firm's fastest growing solution.

A key aspect of the firm's success is its "Trusted Advisor" approach. Most TGaS Advisors associates are 20-year industry veterans, coming to the firm from such companies as Wyeth (Pfizer), GlaxoSmithKline, Bristol-Myers Squibb, AstraZeneca, Roche Pharmaceuticals, King Pharmaceuticals, Abbott Laboratories, Yamanouchi (Astellas), Thomson Reuters, IMS Health and SimStar (Rosetta Interactive).

About TGaS® Advisors

TGaS Advisors is the leading benchmarking and advisory services firm serving pharmaceutical commercial operations organizations. The TGaS Advisors roster includes the top 10 and the majority of the top 50 pharmaceutical companies with operations in the U.S. market. The firm provides the only comprehensive series of benchmarking solutions and advisory services for objectively improving the strategy and effectiveness of pharmaceutical operations organizations. TGaS Advisors, based in East Norriton, Penn., is an operating division of KnowledgePoint360 Group, a global leader in communications and information services to healthcare professionals.

About KnowledgePoint360

KnowledgePoint360 provides a broad range of medical communications services from offices in the U.S., the U.K., and Germany, including medical education, publication support, live educational meetings ranging from international congresses to dinner meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions to support speaker programs, benchmark-based advisory services, and strategic consulting.

KnowledgePoint360 businesses include ACUMED, BlueMomentum, Clinical Bridges, CodonMedical, eMedFusion, FireKite, Gardiner-Caldwell Communications, GeoMed, Interphase, Medex-Media, Physicians World, Physicians World Europe, Physicians World Speakers Bureau, Scientific Connexions, StemScientific, and TGaS Advisors. Headquarters are in Secaucus, N.J., with additional offices in Macclesfield, Maidenhead, Tytherington and London, U.K.; Newtown and East Norriton, Penn., New York, Chicago, and San Bruno, Calif.; and Mannheim, Germany. For more information, visit www.knowledgepoint360.com.